ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting GLP-1RA Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-16S16171
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Long acting GLP 1RA Market Research Report 2023
BUY CHAPTERS

Global Long-acting GLP-1RA Market Research Report 2025

Code: QYRE-Auto-16S16171
Report
June 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Astrazeneca plc
Eli Lily
Hansoh Pharmaceutical
Novo Nordisk

Long-acting GLP-1RA Market Size

The global market for Long-acting GLP-1RA was valued at US$ 20020 million in the year 2024 and is projected to reach a revised size of US$ 32980 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Long-acting GLP-1RA Market

Long-acting GLP-1RA Market

A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
Long-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is experiencing rapid growth in the diabetes treatment sector. The market size is continually expanding, with increasing sales demonstrating its significant potential. Long-acting GLP-1RA medications are favored for their unique effects in improving blood sugar control while aiding in weight reduction, gradually becoming a mainstream choice for type 2 diabetes treatment. Beyond glucose regulation, their specific uses extend to assisting patients in achieving weight management goals. In the future, long-acting GLP-1RA is poised to optimize formulations, mitigate side effects, and broaden its reach to a more diverse patient population, offering more effective and personalized treatment options for diabetes patients worldwide.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting GLP-1RA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting GLP-1RA.
The Long-acting GLP-1RA market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting GLP-1RA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting GLP-1RA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting GLP-1RA Market Report

Report Metric Details
Report Name Long-acting GLP-1RA Market
Accounted market size in year US$ 20020 million
Forecasted market size in 2031 US$ 32980 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Liraglutide
  • Albiglutide
  • Dulaglutide
  • Semaglutide
  • Polyethylene Glycol Loxenatide
  • Exenatide Microspheres
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, GSK, AstraZeneca, Eli Lily, Hansoh Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-acting GLP-1RA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-acting GLP-1RA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Long-acting GLP-1RA Market growing?

Ans: The Long-acting GLP-1RA Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Long-acting GLP-1RA Market size in 2031?

Ans: The Long-acting GLP-1RA Market size in 2031 will be US$ 32980 million.

Who are the main players in the Long-acting GLP-1RA Market report?

Ans: The main players in the Long-acting GLP-1RA Market are Novo Nordisk, GSK, AstraZeneca, Eli Lily, Hansoh Pharmaceutical

What are the Application segmentation covered in the Long-acting GLP-1RA Market report?

Ans: The Applications covered in the Long-acting GLP-1RA Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Long-acting GLP-1RA Market report?

Ans: The Types covered in the Long-acting GLP-1RA Market report are Liraglutide, Albiglutide, Dulaglutide, Semaglutide, Polyethylene Glycol Loxenatide, Exenatide Microspheres

1 Long-acting GLP-1RA Market Overview
1.1 Product Definition
1.2 Long-acting GLP-1RA by Type
1.2.1 Global Long-acting GLP-1RA Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liraglutide
1.2.3 Albiglutide
1.2.4 Dulaglutide
1.2.5 Semaglutide
1.2.6 Polyethylene Glycol Loxenatide
1.2.7 Exenatide Microspheres
1.3 Long-acting GLP-1RA by Application
1.3.1 Global Long-acting GLP-1RA Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Long-acting GLP-1RA Market Size Estimates and Forecasts
1.4.1 Global Long-acting GLP-1RA Revenue 2020-2031
1.4.2 Global Long-acting GLP-1RA Sales 2020-2031
1.4.3 Global Long-acting GLP-1RA Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Long-acting GLP-1RA Market Competition by Manufacturers
2.1 Global Long-acting GLP-1RA Sales Market Share by Manufacturers (2020-2025)
2.2 Global Long-acting GLP-1RA Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Long-acting GLP-1RA Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Long-acting GLP-1RA, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting GLP-1RA, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting GLP-1RA, Product Type & Application
2.7 Global Key Manufacturers of Long-acting GLP-1RA, Date of Enter into This Industry
2.8 Global Long-acting GLP-1RA Market Competitive Situation and Trends
2.8.1 Global Long-acting GLP-1RA Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting GLP-1RA Players Market Share by Revenue
2.8.3 Global Long-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting GLP-1RA Market Scenario by Region
3.1 Global Long-acting GLP-1RA Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Long-acting GLP-1RA Sales by Region: 2020-2031
3.2.1 Global Long-acting GLP-1RA Sales by Region: 2020-2025
3.2.2 Global Long-acting GLP-1RA Sales by Region: 2026-2031
3.3 Global Long-acting GLP-1RA Revenue by Region: 2020-2031
3.3.1 Global Long-acting GLP-1RA Revenue by Region: 2020-2025
3.3.2 Global Long-acting GLP-1RA Revenue by Region: 2026-2031
3.4 North America Long-acting GLP-1RA Market Facts & Figures by Country
3.4.1 North America Long-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Long-acting GLP-1RA Sales by Country (2020-2031)
3.4.3 North America Long-acting GLP-1RA Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting GLP-1RA Market Facts & Figures by Country
3.5.1 Europe Long-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Long-acting GLP-1RA Sales by Country (2020-2031)
3.5.3 Europe Long-acting GLP-1RA Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting GLP-1RA Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting GLP-1RA Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Long-acting GLP-1RA Sales by Region (2020-2031)
3.6.3 Asia Pacific Long-acting GLP-1RA Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting GLP-1RA Market Facts & Figures by Country
3.7.1 Latin America Long-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Long-acting GLP-1RA Sales by Country (2020-2031)
3.7.3 Latin America Long-acting GLP-1RA Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting GLP-1RA Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Long-acting GLP-1RA Sales by Country (2020-2031)
3.8.3 Middle East and Africa Long-acting GLP-1RA Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting GLP-1RA Sales by Type (2020-2031)
4.1.1 Global Long-acting GLP-1RA Sales by Type (2020-2025)
4.1.2 Global Long-acting GLP-1RA Sales by Type (2026-2031)
4.1.3 Global Long-acting GLP-1RA Sales Market Share by Type (2020-2031)
4.2 Global Long-acting GLP-1RA Revenue by Type (2020-2031)
4.2.1 Global Long-acting GLP-1RA Revenue by Type (2020-2025)
4.2.2 Global Long-acting GLP-1RA Revenue by Type (2026-2031)
4.2.3 Global Long-acting GLP-1RA Revenue Market Share by Type (2020-2031)
4.3 Global Long-acting GLP-1RA Price by Type (2020-2031)
5 Segment by Application
5.1 Global Long-acting GLP-1RA Sales by Application (2020-2031)
5.1.1 Global Long-acting GLP-1RA Sales by Application (2020-2025)
5.1.2 Global Long-acting GLP-1RA Sales by Application (2026-2031)
5.1.3 Global Long-acting GLP-1RA Sales Market Share by Application (2020-2031)
5.2 Global Long-acting GLP-1RA Revenue by Application (2020-2031)
5.2.1 Global Long-acting GLP-1RA Revenue by Application (2020-2025)
5.2.2 Global Long-acting GLP-1RA Revenue by Application (2026-2031)
5.2.3 Global Long-acting GLP-1RA Revenue Market Share by Application (2020-2031)
5.3 Global Long-acting GLP-1RA Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Long-acting GLP-1RA Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Long-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Long-acting GLP-1RA Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novo Nordisk Long-acting GLP-1RA Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Long-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Long-acting GLP-1RA Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Eli Lily
6.5.1 Eli Lily Company Information
6.5.2 Eli Lily Description and Business Overview
6.5.3 Eli Lily Long-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lily Long-acting GLP-1RA Product Portfolio
6.5.5 Eli Lily Recent Developments/Updates
6.6 Hansoh Pharmaceutical
6.6.1 Hansoh Pharmaceutical Company Information
6.6.2 Hansoh Pharmaceutical Description and Business Overview
6.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolio
6.6.5 Hansoh Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting GLP-1RA Industry Chain Analysis
7.2 Long-acting GLP-1RA Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting GLP-1RA Production Mode & Process Analysis
7.4 Long-acting GLP-1RA Sales and Marketing
7.4.1 Long-acting GLP-1RA Sales Channels
7.4.2 Long-acting GLP-1RA Distributors
7.5 Long-acting GLP-1RA Customer Analysis
8 Long-acting GLP-1RA Market Dynamics
8.1 Long-acting GLP-1RA Industry Trends
8.2 Long-acting GLP-1RA Market Drivers
8.3 Long-acting GLP-1RA Market Challenges
8.4 Long-acting GLP-1RA Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Astrazeneca plc
Eli Lily
Hansoh Pharmaceutical
Novo Nordisk
List of Tables
 Table 1. Global Long-acting GLP-1RA Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Long-acting GLP-1RA Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Long-acting GLP-1RA Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Long-acting GLP-1RA Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Long-acting GLP-1RA Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Long-acting GLP-1RA Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Long-acting GLP-1RA Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Long-acting GLP-1RA Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Long-acting GLP-1RA, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-acting GLP-1RA, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-acting GLP-1RA, Product Type & Application
 Table 12. Global Key Manufacturers of Long-acting GLP-1RA, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting GLP-1RA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting GLP-1RA as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting GLP-1RA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Long-acting GLP-1RA Sales by Region (2020-2025) & (K Units)
 Table 18. Global Long-acting GLP-1RA Sales Market Share by Region (2020-2025)
 Table 19. Global Long-acting GLP-1RA Sales by Region (2026-2031) & (K Units)
 Table 20. Global Long-acting GLP-1RA Sales Market Share by Region (2026-2031)
 Table 21. Global Long-acting GLP-1RA Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Long-acting GLP-1RA Revenue Market Share by Region (2020-2025)
 Table 23. Global Long-acting GLP-1RA Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Long-acting GLP-1RA Revenue Market Share by Region (2026-2031)
 Table 25. North America Long-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Long-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 27. North America Long-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 28. North America Long-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Long-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Long-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Long-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Long-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Long-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Long-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Long-acting GLP-1RA Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Long-acting GLP-1RA Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Long-acting GLP-1RA Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Long-acting GLP-1RA Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Long-acting GLP-1RA Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Long-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Long-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Long-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Long-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Long-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Long-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Long-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Long-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Long-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Long-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Long-acting GLP-1RA Sales (K Units) by Type (2020-2025)
 Table 51. Global Long-acting GLP-1RA Sales (K Units) by Type (2026-2031)
 Table 52. Global Long-acting GLP-1RA Sales Market Share by Type (2020-2025)
 Table 53. Global Long-acting GLP-1RA Sales Market Share by Type (2026-2031)
 Table 54. Global Long-acting GLP-1RA Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Long-acting GLP-1RA Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Long-acting GLP-1RA Revenue Market Share by Type (2020-2025)
 Table 57. Global Long-acting GLP-1RA Revenue Market Share by Type (2026-2031)
 Table 58. Global Long-acting GLP-1RA Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Long-acting GLP-1RA Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Long-acting GLP-1RA Sales (K Units) by Application (2020-2025)
 Table 61. Global Long-acting GLP-1RA Sales (K Units) by Application (2026-2031)
 Table 62. Global Long-acting GLP-1RA Sales Market Share by Application (2020-2025)
 Table 63. Global Long-acting GLP-1RA Sales Market Share by Application (2026-2031)
 Table 64. Global Long-acting GLP-1RA Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Long-acting GLP-1RA Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Long-acting GLP-1RA Revenue Market Share by Application (2020-2025)
 Table 67. Global Long-acting GLP-1RA Revenue Market Share by Application (2026-2031)
 Table 68. Global Long-acting GLP-1RA Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Long-acting GLP-1RA Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Long-acting GLP-1RA Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Long-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Long-acting GLP-1RA Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Novo Nordisk Company Information
 Table 81. Novo Nordisk Description and Business Overview
 Table 82. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novo Nordisk Long-acting GLP-1RA Product
 Table 84. Novo Nordisk Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca Long-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AstraZeneca Long-acting GLP-1RA Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. Eli Lily Company Information
 Table 91. Eli Lily Description and Business Overview
 Table 92. Eli Lily Long-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eli Lily Long-acting GLP-1RA Product
 Table 94. Eli Lily Recent Developments/Updates
 Table 95. Hansoh Pharmaceutical Company Information
 Table 96. Hansoh Pharmaceutical Description and Business Overview
 Table 97. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hansoh Pharmaceutical Long-acting GLP-1RA Product
 Table 99. Hansoh Pharmaceutical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Long-acting GLP-1RA Distributors List
 Table 103. Long-acting GLP-1RA Customers List
 Table 104. Long-acting GLP-1RA Market Trends
 Table 105. Long-acting GLP-1RA Market Drivers
 Table 106. Long-acting GLP-1RA Market Challenges
 Table 107. Long-acting GLP-1RA Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting GLP-1RA
 Figure 2. Global Long-acting GLP-1RA Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Long-acting GLP-1RA Market Share by Type: 2024 & 2031
 Figure 4. Liraglutide Product Picture
 Figure 5. Albiglutide Product Picture
 Figure 6. Dulaglutide Product Picture
 Figure 7. Semaglutide Product Picture
 Figure 8. Polyethylene Glycol Loxenatide Product Picture
 Figure 9. Exenatide Microspheres Product Picture
 Figure 10. Global Long-acting GLP-1RA Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Long-acting GLP-1RA Market Share by Application: 2024 & 2031
 Figure 12. Hospital
 Figure 13. Clinic
 Figure 14. Other
 Figure 15. Global Long-acting GLP-1RA Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Long-acting GLP-1RA Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Long-acting GLP-1RA Sales (2020-2031) & (K Units)
 Figure 18. Global Long-acting GLP-1RA Average Price (US$/Unit) & (2020-2031)
 Figure 19. Long-acting GLP-1RA Report Years Considered
 Figure 20. Long-acting GLP-1RA Sales Share by Manufacturers in 2024
 Figure 21. Global Long-acting GLP-1RA Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Long-acting GLP-1RA Players: Market Share by Revenue in Long-acting GLP-1RA in 2024
 Figure 23. Long-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Long-acting GLP-1RA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Long-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 26. North America Long-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 27. United States Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Long-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 30. Europe Long-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Long-acting GLP-1RA Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Long-acting GLP-1RA Revenue Market Share by Region (2020-2031)
 Figure 38. China Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Long-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Long-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Colombia Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Long-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Long-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Long-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Long-acting GLP-1RA by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Long-acting GLP-1RA by Type (2020-2031)
 Figure 58. Global Long-acting GLP-1RA Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Long-acting GLP-1RA by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Long-acting GLP-1RA by Application (2020-2031)
 Figure 61. Global Long-acting GLP-1RA Price (US$/Unit) by Application (2020-2031)
 Figure 62. Long-acting GLP-1RA Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Ultra Long acting GLP 1RA Market Research Report 2024
Global Short acting GLP 1RA Market Research Report 2024
Global GLP 1RA Therapy Market Research Report 2024
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Global GLP 1 Agonists for Obesity Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonist Injection Market Research Report 2024
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Liraglutide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global GLP 1 Drugs Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global GLP 1 Injection Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions